GB0126395D0 - Pyrazolo[4,3]pyrimidine derivatives and their use in treating disease - Google Patents

Pyrazolo[4,3]pyrimidine derivatives and their use in treating disease

Info

Publication number
GB0126395D0
GB0126395D0 GB0126395A GB0126395A GB0126395D0 GB 0126395 D0 GB0126395 D0 GB 0126395D0 GB 0126395 A GB0126395 A GB 0126395A GB 0126395 A GB0126395 A GB 0126395A GB 0126395 D0 GB0126395 D0 GB 0126395D0
Authority
GB
United Kingdom
Prior art keywords
pyrazolo
pyrimidine derivatives
treating disease
disease
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0126395A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB0126395A priority Critical patent/GB0126395D0/en
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Publication of GB0126395D0 publication Critical patent/GB0126395D0/en
Priority to HN2002000317A priority patent/HN2002000317A/en
Priority to DO2002000482A priority patent/DOP2002000482A/en
Priority to PCT/IB2002/004385 priority patent/WO2003037899A1/en
Priority to BR0214096-9A priority patent/BR0214096A/en
Priority to MXPA04004171A priority patent/MXPA04004171A/en
Priority to EP02777623A priority patent/EP1440073A1/en
Priority to JP2003540180A priority patent/JP2005511575A/en
Priority to CA002466824A priority patent/CA2466824A1/en
Priority to PA20028557401A priority patent/PA8557401A1/en
Priority to PE2002001070A priority patent/PE20030702A1/en
Priority to UY27522A priority patent/UY27522A1/en
Priority to US10/283,514 priority patent/US20030195205A1/en
Priority to GT200200226A priority patent/GT200200226A/en
Priority to ARP020104152A priority patent/AR037329A1/en
Priority to TW091132424A priority patent/TW200300081A/en
Priority to SV2002001373A priority patent/SV2004001373A/en
Ceased legal-status Critical Current

Links

GB0126395A 2001-11-02 2001-11-02 Pyrazolo[4,3]pyrimidine derivatives and their use in treating disease Ceased GB0126395D0 (en)

Priority Applications (17)

Application Number Priority Date Filing Date Title
GB0126395A GB0126395D0 (en) 2001-11-02 2001-11-02 Pyrazolo[4,3]pyrimidine derivatives and their use in treating disease
HN2002000317A HN2002000317A (en) 2001-11-02 2002-10-01 PDE9 INHIBITORS FOR TREATMENT OF CARDIOVASCULAR DISORDERS
DO2002000482A DOP2002000482A (en) 2001-11-02 2002-10-09 PDE9 INHIBITORS FOR TREATMENT OF CARDIOVASCULAR DISORDERS
PCT/IB2002/004385 WO2003037899A1 (en) 2001-11-02 2002-10-22 Pde9 inhibitors for treating cardiovascular disorders
BR0214096-9A BR0214096A (en) 2001-11-02 2002-10-22 Pde9 inhibitors for the treatment of cardiovascular disorders
MXPA04004171A MXPA04004171A (en) 2001-11-02 2002-10-22 Pde9 inhibitors for treating cardiovascular disorders.
EP02777623A EP1440073A1 (en) 2001-11-02 2002-10-22 Pde9 inhibitors for treating cardiovascular disorders
JP2003540180A JP2005511575A (en) 2001-11-02 2002-10-22 PDE9 inhibitors for treating cardiovascular disorders
CA002466824A CA2466824A1 (en) 2001-11-02 2002-10-22 Pde9 inhibitors for treating cardiovascular disorders
PA20028557401A PA8557401A1 (en) 2001-11-02 2002-10-29 PDE9 INHIBITORS FOR TREATMENT OF CARDIOVASCULAR DISORDERS
US10/283,514 US20030195205A1 (en) 2001-11-02 2002-10-30 PDE9 inhibitors for treating cardiovascular disorders
PE2002001070A PE20030702A1 (en) 2001-11-02 2002-10-30 PDE9 INHIBITORS FOR THE TREATMENT OF CARDIOVASCULAR DISORDERS
UY27522A UY27522A1 (en) 2001-11-02 2002-10-30 PDE9 INHIBITORS FOR TREATMENT OF CARDIOVASCULAR DISORDERS
GT200200226A GT200200226A (en) 2001-11-02 2002-10-31 PDE9 INHIBITORS FOR TREATMENT OF CARDIOVASCULAR DISORDERS
ARP020104152A AR037329A1 (en) 2001-11-02 2002-10-31 PIRAZOLO PIRIMIDINONA COMPOUNDS, PROCEDURES FOR THE PREPARATION OF THE SAME, PHARMACEUTICAL COMPOSITIONS OF THE SAME AND USES OF THE SAME IN THE PREPARATION OF MEDICINES
TW091132424A TW200300081A (en) 2001-11-02 2002-11-01 Pde9 inhibitors for treating cardiovascular disorders
SV2002001373A SV2004001373A (en) 2001-11-02 2002-11-01 PDE9 INHIBITORS FOR TREATMENT OF CARDIOVASCULAR DISORDERS. REF. PCS22051

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0126395A GB0126395D0 (en) 2001-11-02 2001-11-02 Pyrazolo[4,3]pyrimidine derivatives and their use in treating disease

Publications (1)

Publication Number Publication Date
GB0126395D0 true GB0126395D0 (en) 2002-01-02

Family

ID=9925068

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0126395A Ceased GB0126395D0 (en) 2001-11-02 2001-11-02 Pyrazolo[4,3]pyrimidine derivatives and their use in treating disease

Country Status (2)

Country Link
GB (1) GB0126395D0 (en)
GT (1) GT200200226A (en)

Also Published As

Publication number Publication date
GT200200226A (en) 2003-06-06

Similar Documents

Publication Publication Date Title
PL377239A1 (en) Novel amino-substituted dihydropyrimido[4,5-d]pyrimidinone derivatives, their manufacture and use as pharmaceutical agents
HUP0204346A3 (en) Herbicidal n-(5,7-dimethoxy[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)arylsulfonamide derivatives, preparation and use thereof
IL189865A0 (en) 1, 5 - disubstituted - 3,4 - dihydro - 1h - pyrimido [4,5-d] pyrimidin - 2 - one compounds and their use in treating csbp/p38 kinase mediated diseases
IL219669A0 (en) PYRAZOLO [1,5-a]PYRIDINES AND USE THEREOF IN THE PREPARATION OF A MEDICAMENT
HUP0402113A3 (en) 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity, preparation and use thereof
HUP0203425A3 (en) Quinazoline derivatives, process for their preparation and their use
IL166100A0 (en) 7,8,9-10-tetrahydro-6h-azepino,6,7,8,9-tetrahydro-pyrido and 2,3-dihydro-2h-pyrroloÄ2,1-bÜ quinazolinone derivatives
HUP0103836A3 (en) Pyrrolo[2,3d]pyrimidine compositions and their use
AU2002223599A1 (en) Pyrimidinone derivatives and their use in the treatment of atherosclerosis
AU2002359126A8 (en) Benzodiazepine derivatives, preparation thereof and use thereof
IL160402A0 (en) Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido {1,2-a} pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo{1,2-pyrimidin-5 (1h) one derivatives
AU1224902A (en) 2-pyridinyl-6,7,8,9-tetrahydropyrimido(1,2-a)pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo(1,2-a)pyrimidin-5(1H)one derivatives
AU2002359123A8 (en) Benzodiazepine derivatives, preparation thereof and use thereof
IL133633A0 (en) 4-OXO - 3, 5-DIHYDRO - 4H - PYRIDAZINO [4, 5 - b] - INDOLE - 1-ACETAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPY
TWI320413B (en) 1,4-diazabicyclo [ 3.2.2 ] nonanecarboxamide derivatives, preparation thereof and therapeutic use thereof
HUP0600238A3 (en) Benzothiazole- and benzoxazole-4,7-dione derivatives and their use
HK1062173A1 (en) Imidazolidine derivatives, their preparation, and their use in the proparation of antinflamatory agent
AU2002349013A1 (en) Use of 7h-pyrrolo(2,3-d)pyrimidine derivatives in the treatment of solid tumor diseases
GB0126395D0 (en) Pyrazolo[4,3]pyrimidine derivatives and their use in treating disease
PL371201A1 (en) 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-carboxamide derivatives, their preparation and therapeutic use
IL163683A0 (en) Substituted 3-phenyl-5-alkoxy-1,3,4,-oxadiazol-2-ones, their preparation and use in medicaments
PT1325010E (en) 3,4-DIHYDROPYRIMIDO [1,2-A] PYRIMIDINES AND 3,4-DIHYDROPYRAZINE [1,2-A] PYRIMIDINES REPLACED
AU2002210686A1 (en) Flavan compounds, their preparation and their use in therapy
GB0307389D0 (en) Amino pyrazolo[1,5-a]pyrimidine compounds and their use in medicine
HRP20020971A2 (en) 4,5-dihydro-thiazo-2-ylamine derivatives and their use as no-inhibitors

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)